418 related articles for article (PubMed ID: 36064461)
1. Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: a phase I pilot study with a 3-year follow-up.
Zhang C; Huang L; Wang X; Zhou X; Zhang X; Li L; Wu J; Kou M; Cai C; Lian Q; Zhou X
Stem Cell Res Ther; 2022 Sep; 13(1):451. PubMed ID: 36064461
[TBL] [Abstract][Full Text] [Related]
2. Role and effect of vein-transplanted human umbilical cord mesenchymal stem cells in the repair of diabetic foot ulcers in rats.
Shi R; Lian W; Jin Y; Cao C; Han S; Yang X; Zhao S; Li M; Zhao H
Acta Biochim Biophys Sin (Shanghai); 2020 Jun; 52(6):620-630. PubMed ID: 32484226
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem Cells Promote Wound Healing and Effects on Expression of Matrix Metalloproteinases-8 and 9 in the Wound Tissue of Diabetic Rats.
Wei L; Xu Y; Zhang L; Yang L; Zhao RC; Zhao D
Stem Cells Dev; 2023 Jan; 32(1-2):25-31. PubMed ID: 36322784
[TBL] [Abstract][Full Text] [Related]
4. Three-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer: A case report.
Zeng X; Tang Y; Hu K; Jiao W; Ying L; Zhu L; Liu J; Xu J
Medicine (Baltimore); 2017 Dec; 96(51):e9212. PubMed ID: 29390468
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial.
Gu J; Huang L; Zhang C; Wang Y; Zhang R; Tu Z; Wang H; Zhou X; Xiao Z; Liu Z; Hu X; Ke Z; Wang D; Liu L
Stem Cell Res Ther; 2020 Feb; 11(1):43. PubMed ID: 32014055
[TBL] [Abstract][Full Text] [Related]
6. Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study.
Yang Y; Pang M; Du C; Liu ZY; Chen ZH; Wang NX; Zhang LM; Chen YY; Mo J; Dong JW; Xie PG; Wang QY; Liu B; Rong LM
Cytotherapy; 2021 Jan; 23(1):57-64. PubMed ID: 33218835
[TBL] [Abstract][Full Text] [Related]
7. One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment.
Shi L; Zheng Y; Cheng Z; Ji N; Niu C; Wang Y; Huang T; Li R; Huang M; Chen X; Shu L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J; Feng G
Stem Cell Res Ther; 2022 Jul; 13(1):321. PubMed ID: 35842684
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of intramuscular human placenta-derived mesenchymal stromal-like cells (cenplacel [PDA-002]) in patients who have a diabetic foot ulcer with peripheral arterial disease.
Wu SC; Pollak R; Frykberg RG; Zhou W; Karnoub M; Jankovic V; Fischkoff SA; Chitkara D
Int Wound J; 2017 Oct; 14(5):823-829. PubMed ID: 28133924
[TBL] [Abstract][Full Text] [Related]
9. Changing the patterns of hospitalized diabetic foot ulcer (DFU) over a 5-year period in a multi-disciplinary setting in Thailand.
Thewjitcharoen Y; Sripatpong J; Krittiyawong S; Porramatikul S; Srikummoon T; Mahaudomporn S; Butadej S; Nakasatien S; Himathongkam T
BMC Endocr Disord; 2020 Jun; 20(1):89. PubMed ID: 32571283
[TBL] [Abstract][Full Text] [Related]
10. External Application of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Hyaluronic Acid Gel Repairs Foot Wounds of Types I and II Diabetic Rats Through Paracrine Action Mode.
Chen J; Liu Y; Zhang J; Yang Y; Liang H; Li T; Yan L; Zhou L; Shan L; Wang H
Stem Cells Transl Med; 2023 Oct; 12(10):689-706. PubMed ID: 37639574
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
[TBL] [Abstract][Full Text] [Related]
12. Comparative study on the efficacy of PRP gel and UC-MSCs gel as adjuvant therapies in the treatment of DFU wounds.
Jin Y; Meng M; Zhang Y; Mo L; Gao H; Liu Y; Wu J; Yang P; Zhang Z; Jia F; Zhao Y; Huang Y
Skin Res Technol; 2024 Jan; 30(1):e13549. PubMed ID: 38174781
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Peripheral Arterial Disease in Diabetic Foot Ulcer Patients and its Impact in Limb Salvage.
Azhar A; Basheer M; Abdelgawad MS; Roshdi H; Kamel MF
Int J Low Extrem Wounds; 2023 Sep; 22(3):518-523. PubMed ID: 34142882
[TBL] [Abstract][Full Text] [Related]
14. Translational development of ABCB5
Kerstan A; Dieter K; Niebergall-Roth E; Klingele S; Jünger M; Hasslacher C; Daeschlein G; Stemler L; Meyer-Pannwitt U; Schubert K; Klausmann G; Raab T; Goebeler M; Kraft K; Esterlechner J; Schröder HM; Sadeghi S; Ballikaya S; Gasser M; Waaga-Gasser AM; Murphy GF; Orgill DP; Frank NY; Ganss C; Scharffetter-Kochanek K; Frank MH; Kluth MA
Stem Cell Res Ther; 2022 Sep; 13(1):455. PubMed ID: 36064604
[TBL] [Abstract][Full Text] [Related]
15. Stem and Somatic Cell Monotherapy for the Treatment of Diabetic Foot Ulcers: Review of Clinical Studies and Mechanisms of Action.
Krasilnikova OA; Baranovskii DS; Lyundup AV; Shegay PV; Kaprin AD; Klabukov ID
Stem Cell Rev Rep; 2022 Aug; 18(6):1974-1985. PubMed ID: 35476187
[TBL] [Abstract][Full Text] [Related]
16. Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?
Soria B; Escacena N; Gonzaga A; Soria-Juan B; Andreu E; Hmadcha A; Gutierrez-Vilchez AM; Cahuana G; Tejedo JR; De la Cuesta A; Miralles M; García-Gómez S; Hernández-Blasco L
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139339
[TBL] [Abstract][Full Text] [Related]
17. Safety evaluation of human umbilical cord-mesenchymal stem cells in type 2 diabetes mellitus treatment: A phase 2 clinical trial.
Lian XF; Lu DH; Liu HL; Liu YJ; Yang Y; Lin Y; Xie F; Huang CH; Wu HM; Long AM; Hui CJ; Shi Y; Chen Y; Gao YF; Zhang F
World J Clin Cases; 2023 Jul; 11(21):5083-5096. PubMed ID: 37583846
[TBL] [Abstract][Full Text] [Related]
18. Predictors of healing, ulcer recurrence and persistence, amputation and mortality in type 2 diabetic patients with diabetic foot: a 10-year retrospective cohort study.
Gazzaruso C; Gallotti P; Pujia A; Montalcini T; Giustina A; Coppola A
Endocrine; 2021 Jan; 71(1):59-68. PubMed ID: 32712853
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study.
Zhu Y; Huang C; Zheng L; Li Q; Ge J; Geng S; Zhai M; Chen X; Yuan H; Li Y; Jia W; Sun K; Li Y; Ye T; Zhao Z; Liu H; Liu Z; Jiang H
Stem Cell Res Ther; 2024 Apr; 15(1):122. PubMed ID: 38679727
[TBL] [Abstract][Full Text] [Related]
20. Function and mechanism of mesenchymal stem cells in the healing of diabetic foot wounds.
Yu X; Liu P; Li Z; Zhang Z
Front Endocrinol (Lausanne); 2023; 14():1099310. PubMed ID: 37008908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
